Pioneering diagnostics

 Facts & Figures

A world leader in the field of in vitro diagnostics for 50 years, bioMérieux provides diagnostic solutions (reagents, instruments, software and services) which determine the source of disease and contamination to improve patient health and ensure product safety.

What We Do

Our Assets

  • A strong commitment and a long-term vision (family-owned company).
  • World leader in clinical microbiology.
  • The pioneer and number 1 in industrial microbiology for the agri-food, cosmetics and pharmaceutical industries.
  • A broad international footprint.
  • Strong R&D investment: about 12% of sales.
  • Installed base of some 84,500 instruments worldwide (as of December 31, 2015).

Key Figures

  • € 1.965 billion in sales (as of Dec. 31, 2015)
  • 2 main applications:
    • Clinical Diagnostics: ~ 82% of sales,
    • Industrial Microbiology: ~ 18% of sales.
  • Over 9,438 employees (full-time equivalents) at the end of December 2015.
  • Present in more than 150 countries through 42 subsidiaries,
    • 90% of sales outside France.
  • 19 production sites (nearly 3,000 employees)
  • 20 R&D sites (more than 1,400 employees)
  • bioMérieux is listed on NYSE Euronext Paris.